Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HBI-06-x
- Development stage
- Unknown
- Lead developer
- Human Biome Institute
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral, Intragastric, Intraduodenal, Intrajejunal, Colonoscopy, Rectal
01
Overview
**HBI-06-x** is a Human Biome microbiota-based new-generation biotherapeutic program being developed for antibiotic-resistant bacterial infections. The intended therapeutic approach is to restore or deliberately modulate intestinal microbiota using a defined microbiome-derived medicinal product; Human Biome describes its new-generation biotherapeutics as potentially comprising bacteria, bacteriophages, proteins, and metabolites or postbiotics. The exact active composition, bacterial strains, molecular targets, route of administration, and detailed mechanism for HBI-06-x have not been publicly disclosed. ([human-biome.com](https://human-biome.com/hbi-06-x-antibiotic-resistant-bacteria-2/))
Beyond the preview
Go deeper on HBI-06-x.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HBI-06-x.